| Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Revenue | 48 | 55 | 66 | 57 | 61 | 63 | 66 |
| Expenses | 44 | 44 | 46 | 48 | 52 | 51 | 54 |
| EBITDA | 3 | 11 | 20 | 9 | 9 | 11 | 12 |
| Operating Profit % | 6 % | 19 % | 22 % | 14 % | 14 % | 15 % | 17 % |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| Profit Before Tax | -1 | 7 | 16 | 5 | 5 | 6 | 10 |
| Tax | -3 | -1 | -1 | -1 | -0 | 2 | 1 |
| Net Profit | 2 | 8 | 17 | 6 | 5 | 4 | 8 |
| EPS in ₹ | 76.30 | 1.46 | 3.24 | 2.12 | 0.88 | 0.79 | 1.53 |










ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
HDFC Pharma And Healthcare Fund Direct - Growth
Bank of India Small Cap Fund Direct-Growth
HSBC India Export Opportunities Fund Direct-Growth
Mirae Asset Healthcare Fund Direct - Growth
Kotak Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth
Tata ELSS Fund Direct-Growth
UTI Healthcare Fund Direct-Growth
WhiteOak Capital Multi Cap Fund Direct - Growth
LIC MF Focused Fund Direct - Growth
Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth
Bandhan BSE Healthcare Index Fund Direct-Growth 
